by Eric Christianson | Nov 26, 2025 | Cardiovascular Case Studies
Atrial fibrillation (AF) is one of the most commonly tested topics across pharmacy board exams. Whether you’re preparing for the NAPLEX, BCPS, BCACP, or another certification exam, mastering rate control, rhythm control, anticoagulation, and key clinical decision...
by Eric Christianson | Apr 20, 2025 | Free Clinical Practice Quizzes and Videos For Pharmacists
Test Your Knowledge on Atrial Fibrillation For healthcare professionals and students, understanding atrial fibrillation (AFib) is essential. As the most common sustained cardiac arrhythmia, AFib presents frequently in clinical settings and requires a solid grasp of...
by Eric Christianson | Feb 19, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
Diltiazem and verapamil are two non-dihydropyridine calcium channel blockers (non-DHP CCBs) most commonly used in managing certain cardiac conditions. Even though they fall into the same medication class, these medications have important pharmacological differences...
by Eric Christianson | Feb 12, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
This video is part of a three-part series covering new literature that could influenceclinical practice. In this video, I discuss the combined usage of antiplatelets with DOACsin patients with ASCVD risk and atrial fibrillation. Each mechanism of action is reviewed,as...
by Eric Christianson | Aug 28, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Rivaroxaban is classified as a direct oral anticoagulant. It is one of the most commonly used anticoagulants within this class (in addition to apixaban). In this blog post, I’ll share the 5 most important rivaroxaban clinical pearls that may appear in practice...
